Methylisothiazolinone Contact Allergy is Rising to Alarming Heights Also in Southern Sweden
DOI:
https://doi.org/10.2340/00015555-1844Keywords:
contact allergy, patch testing, methylchloroisothiazolinone/methylisothiazolinone 3:1 CAS 55965-84-9, methylchloroisothiazolinone CAS 26172-55-4, methylisothiazolinone CAS 2682-20-4, Kathon CG, dose in �g/cm2, micropipette, patch test sensitisation, preservative.Abstract
The preservative methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) is a well-known sensitiser and present in most baseline series since at least 20 years. The proportions of MCI/MI are 3:1. MI alone has been used as a preservative in occupational and household products, and cosmetics since less than 10 years. MCI/MI tested at 100 ppm fails to detect a significant percentage of contact-allergic reactions to MI. Our aim was to investigate whether a separate test preparation with MI picks up additional cases of contact allergy to MI not detected with MCI/MI 200 ppm. MI was inserted into the baseline series of the Malmö clinic in 2003 starting at 475 ppm, then 900 ppm, then 1,000 ppm, 1,500 ppm and finally 2,000 ppm. In 5,881 consecutively tested dermatitis patients the contact allergy rate for MI varied between 0.5 and 6.5%, with a marked increase in recent years. The contact allergy rate to MI 2,000 ppm alone, not traced by MCI/MI 200 ppm, varied between 0 and 1.9 %. In conclusion, due to the increase of contact allergy to MI not traced by MCI/MI 200 ppm, MI in water at 2,000 ppm should be tested in a baseline series. Independent of patch test technique a dose of 60 µg//cm should not be exceeded to avoid adverse reactions and particularly patch test sensitisation.Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Marléne Isaksson, Inese Hauksson, Monica Hindsén, Ann Pontén, Cecilia Svedman, Magnus Bruze
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.